A Prospective, Randomized, Open-label Clinical Trial to Evaluate the Effect of Tektura (Aliskiren), Angiotensin Inhibitors, Diuretics, and Calcium Channel Blockers on Coronary Flow Reserve in Patients With Type II Diabetes and Hypertension.
Phase of Trial: Phase IV
Latest Information Update: 06 Feb 2017
At a glance
- Drugs Aliskiren; Amlodipine; Hydrochlorothiazide; Lisinopril
- Indications Hypertension
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 30 Jul 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 30 Jul 2012 Planned end date changed from 1 Oct 2011 to 1 Oct 2012 as reported by ClinicalTrials.gov record.